Horan Capital Management cut its position in shares of McKesson Co. (NYSE:MCK) by 1.1% in the first quarter, HoldingsChannel reports. The firm owned 22,954 shares of the company’s stock after selling 264 shares during the period. Horan Capital Management’s holdings in McKesson were worth $2,687,000 as of its most recent SEC filing.

Other institutional investors and hedge funds have also recently bought and sold shares of the company. JPMorgan Chase & Co. increased its holdings in shares of McKesson by 173.2% during the 3rd quarter. JPMorgan Chase & Co. now owns 520,286 shares of the company’s stock valued at $69,016,000 after acquiring an additional 329,814 shares during the last quarter. Mirae Asset Global Investments Co. Ltd. acquired a new position in shares of McKesson during the 3rd quarter valued at about $600,000. Point72 Asset Management L.P. acquired a new position in shares of McKesson during the 3rd quarter valued at about $4,497,000. Lowe Brockenbrough & Co. Inc. increased its holdings in shares of McKesson by 3.1% during the 3rd quarter. Lowe Brockenbrough & Co. Inc. now owns 31,113 shares of the company’s stock valued at $4,127,000 after acquiring an additional 935 shares during the last quarter. Finally, Matthew Goff Investment Advisor LLC increased its holdings in shares of McKesson by 13,239.1% during the 3rd quarter. Matthew Goff Investment Advisor LLC now owns 987,361 shares of the company’s stock valued at $7,402,000 after acquiring an additional 979,959 shares during the last quarter. 86.60% of the stock is owned by institutional investors.

Shares of NYSE:MCK traded up $1.16 during trading on Monday, hitting $117.21. 1,052,288 shares of the stock were exchanged, compared to its average volume of 1,564,436. McKesson Co. has a 1-year low of $106.11 and a 1-year high of $160.84. The firm has a market capitalization of $22.35 billion, a PE ratio of 9.29, a PEG ratio of 1.16 and a beta of 1.24. The company has a current ratio of 1.02, a quick ratio of 0.57 and a debt-to-equity ratio of 0.81.

McKesson (NYSE:MCK) last announced its quarterly earnings data on Thursday, January 31st. The company reported $3.40 earnings per share for the quarter, topping the Thomson Reuters’ consensus estimate of $3.18 by $0.22. McKesson had a positive return on equity of 27.83% and a negative net margin of 0.15%. The company had revenue of $56.21 billion for the quarter, compared to analyst estimates of $55.27 billion. During the same quarter last year, the firm earned $3.41 EPS. On average, sell-side analysts predict that McKesson Co. will post 13.55 EPS for the current year.

The company also recently disclosed a quarterly dividend, which was paid on Monday, April 1st. Stockholders of record on Friday, March 1st were issued a dividend of $0.39 per share. This represents a $1.56 annualized dividend and a dividend yield of 1.33%. The ex-dividend date was Thursday, February 28th. McKesson’s payout ratio is presently 12.36%.

A number of research analysts have recently commented on MCK shares. ValuEngine lowered McKesson from a “sell” rating to a “strong sell” rating in a report on Friday, March 1st. UBS Group assumed coverage on McKesson in a report on Thursday, January 17th. They issued a “neutral” rating and a $134.00 target price on the stock. Zacks Investment Research lowered McKesson from a “hold” rating to a “sell” rating in a report on Thursday, January 3rd. Deutsche Bank raised McKesson from a “sell” rating to a “hold” rating and set a $175.00 target price on the stock in a report on Friday, January 25th. Finally, Barclays reaffirmed a “hold” rating and issued a $130.00 target price on shares of McKesson in a report on Friday, February 1st. One research analyst has rated the stock with a sell rating, nine have given a hold rating and five have assigned a buy rating to the company. McKesson currently has an average rating of “Hold” and a consensus price target of $134.90.

In other news, EVP Lori A. Schechter sold 7,700 shares of McKesson stock in a transaction that occurred on Wednesday, January 16th. The stock was sold at an average price of $122.96, for a total transaction of $946,792.00. Following the sale, the executive vice president now owns 10,000 shares of the company’s stock, valued at approximately $1,229,600. The sale was disclosed in a legal filing with the Securities & Exchange Commission, which is available through the SEC website. 0.87% of the stock is currently owned by company insiders.

TRADEMARK VIOLATION WARNING: “Horan Capital Management Sells 264 Shares of McKesson Co. (MCK)” was first published by The Cerbat Gem and is owned by of The Cerbat Gem. If you are reading this article on another domain, it was copied illegally and reposted in violation of United States and international trademark and copyright legislation. The legal version of this article can be read at https://www.thecerbatgem.com/2019/04/15/horan-capital-management-sells-264-shares-of-mckesson-co-mck.html.

McKesson Company Profile

McKesson Corporation provides pharmaceuticals and medical supplies in the United States and internationally. It operates in three segments: U.S. Pharmaceutical and Specialty Solutions, European Pharmaceutical Solutions, and Medical-Surgical Solutions. The company distributes branded, generic, specialty, biosimilar, and over-the-counter pharmaceutical drugs, as well as other healthcare-related products; and offers practice management, technology, clinical support, and business solutions to community-based oncology and other specialty practices.

Featured Article: Preferred Stock

Want to see what other hedge funds are holding MCK? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for McKesson Co. (NYSE:MCK).

Institutional Ownership by Quarter for McKesson (NYSE:MCK)

Receive News & Ratings for McKesson Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for McKesson and related companies with MarketBeat.com's FREE daily email newsletter.